P H Rayner

752 total citations
40 papers, 553 citations indexed

About

P H Rayner is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, P H Rayner has authored 40 papers receiving a total of 553 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in P H Rayner's work include Sexual Differentiation and Disorders (9 papers), Growth Hormone and Insulin-like Growth Factors (8 papers) and Birth, Development, and Health (5 papers). P H Rayner is often cited by papers focused on Sexual Differentiation and Disorders (9 papers), Growth Hormone and Insulin-like Growth Factors (8 papers) and Birth, Development, and Health (5 papers). P H Rayner collaborates with scholars based in United Kingdom, United States and Tunisia. P H Rayner's co-authors include B T Rudd, Joanne Williams, P R Betts, Jillian R. Mann, Gavin Sandercock, A. Gourévitch, Christine Voss, Daniel McConnell, P.V. Bertrand and N. M. Duignan and has published in prestigious journals such as The Lancet, Clinical Orthopaedics and Related Research and Clinica Chimica Acta.

In The Last Decade

P H Rayner

39 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P H Rayner United Kingdom	15	283	135	127	109	82	40	553
C Preeyasombat Thailand	12	267 0.9×	110 0.8×	65 0.5×	67 0.6×	54 0.7×	28	491
D Knorr Germany	15	328 1.2×	252 1.9×	70 0.6×	109 1.0×	142 1.7×	52	685
Theodore W. AvRuskin United States	11	324 1.1×	96 0.7×	91 0.7×	135 1.2×	70 0.9×	35	524
J.M. Limal France	12	258 0.9×	139 1.0×	185 1.5×	54 0.5×	219 2.7×	31	594
Cyril A. L. Abrams United States	7	277 1.0×	102 0.8×	90 0.7×	39 0.4×	74 0.9×	13	416
Thomas Aceto United States	19	453 1.6×	290 2.1×	297 2.3×	102 0.9×	159 1.9×	51	929
John S. Spaulding United States	9	249 0.9×	145 1.1×	68 0.5×	39 0.4×	56 0.7×	13	427
M.T. Muñoz Spain	8	351 1.2×	195 1.4×	163 1.3×	38 0.3×	106 1.3×	10	588
W. Sorgo Germany	14	223 0.8×	121 0.9×	169 1.3×	107 1.0×	86 1.0×	28	478
P. Travaglini Italy	17	753 2.7×	125 0.9×	105 0.8×	204 1.9×	50 0.6×	54	1.1k

Countries citing papers authored by P H Rayner

Since Specialization

Citations

This map shows the geographic impact of P H Rayner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P H Rayner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P H Rayner more than expected).

Fields of papers citing papers by P H Rayner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P H Rayner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P H Rayner. The network helps show where P H Rayner may publish in the future.

Co-authorship network of co-authors of P H Rayner

This figure shows the co-authorship network connecting the top 25 collaborators of P H Rayner. A scholar is included among the top collaborators of P H Rayner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P H Rayner. P H Rayner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rayner, P H, et al.. (2019). Role of Initiating Supportive Care Preceding Veno-occlusive Disease Diagnosis Following Allogeneic Hematopoietic Stem Cell Transplantation in Children. Journal of Pediatric Hematology/Oncology. 41(6). e395–e401. 2 indexed citations

Sandercock, Gavin, Christine Voss, Daniel McConnell, & P H Rayner. (2009). Ten year secular declines in the cardiorespiratory fitness of affluent English children are largely independent of changes in body mass index. Archives of Disease in Childhood. 95(1). 46–47. 44 indexed citations

Rayner, P H, et al.. (1995). Functional Appliance Therapy in Conjunction with Growth Hormone Treatment. A Case Report. British Journal of Orthodontics. 22(4). 361–365. 6 indexed citations

Rayner, P H, et al.. (1990). An assessment of the benefits of pre‐mixed insulins in childhood diabetes. Practical Diabetes International. 7(3). 122–124. 2 indexed citations

Ackland, F.M., et al.. (1990). Growth Hormone Treatment in Non‐Growth Hormone‐Deficient Children: Effects of Stopping Treatment. Acta Paediatrica. 79(s366). 32–37. 20 indexed citations

Rayner, P H, et al.. (1988). GROWTH HORMONE DEFICIENCY AND THE MEASUREMENT OF SOMATOMEDIN C/IGF‐I: THE INFLUENCE OF SEXUAL MATURATION. Clinical Endocrinology. 28(4). 361–371. 8 indexed citations

Rudd, B T, et al.. (1986). Observations on the role of GH/IGF-1 and sex hormone binding globulin (SHBG) in the pubertal development of growth hormone deficient (GHD) children. European Journal of Endocrinology. 113(4_Suppl). S164–S169. 18 indexed citations

Hocking, M D, S J Newell, & P H Rayner. (1986). Use of human growth hormone in treatment of nesidioblastosis in a neonate.. Archives of Disease in Childhood. 61(7). 706–707. 6 indexed citations

Hocking, M D, et al.. (1986). Metabolic rhythms in adolescents with diabetes during treatment with porcine or human insulin.. Archives of Disease in Childhood. 61(4). 341–345. 2 indexed citations

10.

Griffiths, K., et al.. (1985). Neonatal screening for congenital hypothyroidism by measurement of plasma thyroxine and thyroid stimulating hormone concentrations.. BMJ. 291(6488). 117–120. 19 indexed citations

11.

Rayner, P H. (1984). A home care unit for diabetic children a community orientated approach. Practical Diabetes International. 1(1). 5–6. 7 indexed citations

12.

Rayner, P H, et al.. (1978). Endocrine function and growth retardation in Perthes' Disease. Pediatric Research. 12(2). 159–159. 1 indexed citations

13.

Rayner, P H. (1976). Puberty: precocious and delayed.. BMJ. 1(6022). 1385–1387. 3 indexed citations

14.

Rudd, B T, et al.. (1975). A radioimmunoassay for the estimation of serum dehydroepiandrosterone sulphate in normal and pathological sera. Clinica Chimica Acta. 65(1). 5–13. 62 indexed citations

15.

Rolles, C J, P H Rayner, & Pauline Mackintosh. (1975). ÆTIOLOGY OF JUVENILE DIABETES. The Lancet. 306(7927). 230–230. 16 indexed citations

16.

Rayner, P H. (1971). The use of clomiphene citrate to assess pituitary gonadal function in males with delayed puberty.. Archives of Disease in Childhood. 46(250). 880–880. 1 indexed citations

17.

Rayner, P H. (1969). Androgens and growth.. BMJ. 2(5658). 696.1–696. 1 indexed citations

18.

Bower, Bruce, P H Rayner, & L. Stimmler. (1967). Leucine-sensitive hypoglycaemia treated with diazoxide.. Archives of Disease in Childhood. 42(224). 410–415. 6 indexed citations

19.

Rayner, P H. (1966). Pink Disease. BMJ. 1(5495). 1111–1111.

20.

Rayner, P H, et al.. (1964). PINK DISEASE AND PRIMARY RENAL TUBULAR ACIDOSIS. The Lancet. 284(7369). 1083–1085. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact